HMGB1 and cardiovascular disorder: In addition, norepinephrine (NE) and neuropeptide Y (NPY) released by activated sympathetic activity can also promote the phosphorylation of mitogen-activated protein kinase (MAPK) or the release of high-mobility group protein B1 (HMGB1), thus inducing systemic inflammation and accelerating the development of cardiovascular diseases [27].